Segment # 013

No country has had any consistent success without recognizing the need to balance the prevention of the virus with the treatment of the virus. As we have stated here before the politics of prevention driven by corrupt money and power, has interfered with the development of a cohesive treatment plan internationally. This is not to say that some countries have had great success in thwarting the high mortality rates of COVID. Ironically the much touted health systems of the west are for the most part not included in this group. And in fact as we shall see below the health systems with literally billions in resources have failed miserably. Nobody is more to blame than Anthony Fauci who’s corruption dates back to the 1980’s and his promotion of AZT to fight AIDS. Fauci blocked Hydroxychloroquine and Ivermectin to protect the Emergency Use Authorizations granted by the FDA for big Pharms vaccines. Some experts estimate conservatively the death toll from the inability to make hydroxychloroquine and ivermectin available and from the adverse reactions to the vaccines themselves are between 500,000 and 1,000,000. Anthony Fauci should be held responsible for this atrocity.

Hydroxychloroquine and Sars COV 2 - The Data

April 8, 2020 Hydroxychloroquine for SARS-CoV-2 Infection: How Did We Get Here?

David C. Helfgott, MD - https://www.infectiousdiseaseadvisor.com/home/topics/covid19/is-hydrochloroquine-the-best-treatment-optimal-choice-for-covid-19/

The randomized study by Chen et al17 was small and did not include patients with severe disease. It is notable, however, that only 4 of 62 patients progressed from nonsevere disease to severe disease, implying that the study population had quite mild illness. The other randomized study reported16 examined viral loads and did not find a difference in viral load between hydroxychloroquine-treated and untreated patients at day 7. Conversely, Gautret et al noted improved viral loads among patients in the hydroxychloroquine-treated group compared with untreated patients. However, this was a small, nonrandomized study in which the control group was culled from several hospitals with likely differing standard therapies, and 4 patients in the hydroxychloroquine group who required care in an intensive care unit or died were not included in the analysis.14 The study that evaluated azithromycin was observational in nature and few conclusions could be surmised from the set of azithromycin data.14 It should also be noted that there is concern for QTc prolongation and torsades de pointes with even short-term use of hydroxychloroquine for COVID-19.23

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

https://pubmed.ncbi.nlm.nih.gov › 16115318

Martin J Vincent 1 , Eric Bergeron, Suzanne Benjannet, Bobbie R Erickson, Pierre E Rollin, Thomas G Ksiazek, Nabil G Seidah, Stuart T Nichol

Affiliations

PMID: 16115318
PMCID: PMC1232869
DOI: 10.1186/1743-422X-2-69

Abstract

Background: Severe acute respiratory syndrome (SARS) is caused by a newly discovered coronavirus (SARS-CoV). No effective prophylactic or post-exposure therapy is currently available.

Results: We report, however, that chloroquine has strong antiviral effects on SARS-CoV infection of primate cells. These inhibitory effects are observed when the cells are treated with the drug either before or after exposure to the virus, suggesting both prophylactic and therapeutic advantage. In addition to the well-known functions of chloroquine such as elevations of endosomal pH, the drug appears to interfere with terminal glycosylation of the cellular receptor, angiotensin-converting enzyme 2. This may negatively influence the virus-receptor binding and abrogate the infection, with further ramifications by the elevation of vesicular pH, resulting in the inhibition of infection and spread of SARS CoV at clinically admissible concentrations.

Conclusion: Chloroquine is effective in preventing the spread of SARS CoV in cell culture. Favorable inhibition of virus spread was observed when the cells were either treated with chloroquine prior to or after SARS CoV infection. In addition, the indirect immunofluorescence assay described herein represents a simple and rapid method for screening SARS-CoV antiviral compounds.

The Zelenko protocol ||

https://faculty.utrgv.edu/eleftherios.gkioulekas/zelenko/ZelenkoProtocol.pdf

This webpage curates content related to a treatment protocol that has been proposed by Dr.
Vladimir Zelenko for the SARS-CoV-2 virus, using hydroxychloroquine, zinc sulfate, and
azithtromycin. Dr. Zelenko has recently created his own website crowdprotocol.com to facilitate
medical research using crowd-sourced medical data from frontline primary care physicians from
all around the world. He has also co-authored and submitted his first paper for publication. See
www.thezelenkoprotocol.com for a press release. The website c19study.com is tracking research
studies of hydroxychloroquine.

Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis

Harvey A Risch

American Journal of Epidemiology, Volume 189, Issue 11, November 2020, Pages 1218–1226, https://doi.org/10.1093/aje/kwaa093

Published:

27 May 2020

https://academic.oup.com/aje/article/189/11/1218/5847586

Abstract

More than 1.6 million Americans have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and more than 10 times that number carry antibodies to it. High-risk patients with progressing symptomatic disease currently have only hospitalization treatment, with its high mortality, available to them. An outpatient treatment that prevents hospitalization is desperately needed. Two candidate medications have been widely discussed: remdesivir and hydroxychloroquine (HCQ) + azithromycin (AZ). Remdesivir has shown mild effectiveness in hospitalized inpatients, but no trials in outpatients have been registered. HCQ + AZ has been widely misrepresented in both clinical reports and public media, and results of outpatient trials are not expected until September. Early outpatient illness is very different from later florid disease requiring hospitalization, and the treatments differ. Evidence about use of HCQ alone, or of HCQ + AZ in inpatients, is irrelevant with regard to the efficacy of HCQ + AZ in early high-risk outpatient disease. Five studies, including 2 controlled clinical trials, have demonstrated significant major outpatient treatment efficacy. HCQ + AZ has been used as the standard of care in more than 300,000 older adults with multiple comorbid conditions; the estimated proportion of such patients diagnosed with cardiac arrhythmia attributable to the medications is 47 per 100,000 users, among whom estimated mortality is less than 20% (9/100,000 users), as compared with the 10,000 Americans now dying each week. These medications need to be made widely available and promoted immediately for physicians to prescribe.

Dr. Fauci says all the ‘valid’ scientific data shows hydroxychloroquine isn’t effective in treating coronavirus

Published Wed, Jul 29 202012:31 PM EDTUpdated Fri, Jul 31 20202:39 PM EDT

Berkeley Lovelace Jr.@BerkeleyJr

Key Points

White House coronavirus advisor Dr. Anthony Fauci said that all the “valid” scientific data shows hydroxychloroquine isn’t effective in treating Covid-19.
Fauci said that the public has “got to follow the science,” adding, “if a study that’s good comes out and shows efficacy and safety for hydroxychloroquine or any other drug that we do ... you accept the scientific data.”
The comment by Fauci came a day after Trump said he still thinks hydroxychloroquine works against Covid-19.

Fauci Would Prescribe Chloroquine to Patient Suffering From COVID-19

https://townhall.com/columnists/larryoconnor/2020/03/25/fauci-would-prescribe-chloroquine-to-patient-suffering-from-covid19-n2565678

Larry O'Connor Posted: Mar 25, 2020 10:00 AM

Yesterday, Fauci (who, we had been recently told, was muzzled yet again) went on a bit of a media blitz. He told WMAL radio in Washington, D.C. that the president was doing a great job, that there wasn't any fundamental difference in the foundational principals in attacking the virus and that he wished the media would stop pitting him against the president.

And, on AM 990 in Philadelphia, he talked with Townhall columnist and morning host Chris Stigall about the very real hope in the hydroxychloroquine drug that has been the buzz recently.

"If you're a doctor listening to me right now and a patient with coronavirus feels like they want to try that," Stigall asked, "and you're their doctor, you're not Anthony Fauci the guy running the coronavirus task force, would you say 'alright, we'll give it a whirl'?"

"Yeah, of course, particularly if people have no other option," Fauci said. "These drugs are approved drugs for other reasons. They're anti-malaria drugs, and they're drugs against certain autoimmune diseases like lupus. Physicians throughout the country can prescribe that in an off-label way. Which means they can write it for something it was not approved for."

Pay attention to what the rich and powerful receive as treatment and get that for yourself and family. If they give HCQ to the President of the United States, its a logical bet that they believe it is the best treatment available.

Covid Treatment Protocols Around the World

Hydroxychloroquine and Sars COV 2 - The Data

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

https://pubmed.ncbi.nlm.nih.gov › 16115318

Abstract

Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis

Abstract

Dr. Fauci says all the ‘valid’ scientific data shows hydroxychloroquine isn’t effective in treating coronavirus

Fauci Would Prescribe Chloroquine to Patient Suffering From COVID-19

Pay attention to what the rich and powerful receive as treatment and get that for yourself and family. If they give HCQ to the President of the United States, its a logical bet that they believe it is the best treatment available.

IVERMECTIN

After Mexico City introduced ivermectin plan, COVID hospitalizations and deaths disappeared

An initiative in Mexico City to prescribe ivermectin to COVID-19 positive patients has resulted in a 52–76 percent reduction in hospitalizations.

Covid Treatment Protocols Around the World

Hydroxychloroquine and Sars COV 2 - The Data

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

https://pubmed.ncbi.nlm.nih.gov › 16115318

Abstract

Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients That Should Be Ramped Up Immediately as Key to the Pandemic Crisis

Abstract

Dr. Fauci says all the ‘valid’ scientific data shows hydroxychloroquine isn’t effective in treating coronavirus

Fauci Would Prescribe Chloroquine to Patient Suffering From COVID-19

Pay attention to what the rich and powerful receive as treatment and get that for yourself and family. If they give HCQ to the President of the United States, its a logical bet that they believe it is the best treatment available.

IVERMECTIN

After Mexico City introduced ivermectin plan, COVID hospitalizations and deaths disappeared

An initiative in Mexico City to prescribe ivermectin to COVID-19 positive patients has resulted in a 52–76 percent reduction in hospitalizations.

Greed at Its Very Worst

The Case for Firing Fauci